Active substanceAscorbic acid + RutosideAscorbic acid + Rutoside
Similar drugsTo uncover
  • Ascorutin
    pills inwards 
    ROSLEKS PHARM, LLC     Russia
  • Ascorutin
    pills inwards 
    VIFITEH, CJSC     Russia
  • Ascorutin
    pills inwards 
    LYUMI, LLC     Russia
  • Ascorutin
    pills inwards 
    OZONE, LLC     Russia
  • Ascorutin
    pills inwards 
    ORGANICS, JSC     Russia
  • Ascorutin
    pills inwards 
    ALTAYVITAMINS, CJSC     Russia
  • Ascorutin
    pills inwards 
    MEDISORB, CJSC     Russia
  • Ascorutin
    pills inwards 
    BIOSINTEZ, PAO     Russia
  • Ascorutin
    pills inwards 
    VALENTA PHARM, PAO     Russia
  • Ascorutin
    pills inwards 
  • Ascorutin
    pills inwards 
  • Ascorutin
    pills inwards 
    NGO Farmvilar, OOO     Russia
  • Ascorutin
    pills inwards 
  • Ascorutin D
    pills inwards 
    ROSFARM, CJSC     Russia
  • Ascorutin-UBF
    pills inwards 
    URALBIOFARM, OJSC     Russia
  • Dosage form: & nbsppills
    Composition:

    Composition per one tablet

    Active substances

    Ascorbic acid in terms of 100% substance 0.05 g

    Rutin (Rutozide) in terms of 100% substance 0.05 g

    Excipients

    Sugar refined sugar (sucrose) 0.16643 g

    Microcrystalline cellulose 0.0390 g

    Crospovidone 0.0165 g

    Talc 0.0049 g

    Calcium stearate 0.00317 g

    Weight of a tablet 0.33 g

    Description:

    Tablets of flat-cylindrical shape with a facet and a risk from light yellow to yellow with a grayish or greenish tinge. More light and darker blotches are allowed.

    Pharmacotherapeutic group:Vitamin
    ATX: & nbsp

    C.05.C.A.51   Rutozide in combination with other drugs

    Pharmacodynamics:Combined drug. Restores the deficiency of vitamin C and R. Routin together with ascorbic acid participates in oxidation-reduction processes, has antioxidant properties, prevents oxidation and promotes the deposition of ascorbic acid in tissues. Both components strengthen the vascular wall (promote the formation of intercellular substance and reduce the activity of hyaluronidase), reduce permeability and fragility of capillaries.
    Pharmacokinetics:No data available.
    Indications:

    Hypo and avitaminosis of ascorbic acid and routine.

    As part of complex therapy for varicose veins, trophic disorders and ulcers, with chronic venous insufficiency; with hemorrhagic diathesis.

    Contraindications:

    Increased individual sensitivity to the components of the drug, congenital intolerance to fructose,glucose-galactose malabsorption, sugar / isomaltase deficiency, pregnancy (I trimester), children's age.

    Carefully:

    Conditions accompanied by hypercoagulable blood and a tendency to thrombosis, thrombophlebitis, diabetes mellitus.

    If you have any of these diseases, consult a doctor before taking the drug.

    Pregnancy and lactation:

    The use of the drug is possible during pregnancy (II and III trimester) and during breastfeeding.

    Dosing and Administration:

    Inside, 1 tablet 2-3 times a day during or after a meal. The course of treatment is 2-3 weeks.

    Side effects:

    Allergic reactions (skin rash), dyspeptic disorders, headache.

    If any of the side effects listed in the manual are aggravated, or if you notice any other side effects not listed in the instructions, tell your doctor.

    Overdose:

    To date, cases of overdose have not been reported.

    Interaction:

    Ascorbic acid increases the absorption of drugs of the penicillin and iron group; reduces the clinical effect of heparin and indirect anticoagulants, which requires correction of doses when they are used simultaneously.

    Special instructions:

    Patients with diabetes should take into account that one tablet of the drug contains about 0.2 grams of carbohydrates (0.017 XE).

    Effect on the ability to drive transp. cf. and fur:

    The use of the drug does not affect the performance of potentially hazardous activities requiring special attention and quick reactions (vehicle management, working with moving mechanisms, dispatcher and operator work).

    Form release / dosage:

    Pills.

    Packaging:For 10 tablets in a planar cell package. 2, 3 or 5 contour mesh packages together with instructions for use in a pack of cardboard.
    Storage conditions:

    In a dry, protected from light place at a temperature of no higher than 25 ° C.

    Keep out of the reach of children.

    Shelf life:

    3 years.

    Do not use after the expiration date.

    Terms of leave from pharmacies:Without recipe
    Registration number:LS-000502
    Date of registration:10.08.2010 / 18.05.2012
    Expiration Date:Unlimited
    The owner of the registration certificate:VIFITEH, CJSC VIFITEH, CJSC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp27.09.2017
    Illustrated instructions
      Instructions
      Up